Evidence map›Paper›PMID 42479614›Full record

ArticleInorganic chemistry2026

Access of Adamantane-Type Organotin(IV) Heterochalcogenide Clusters.

Jan Christmann, Niklas Rinn, Yannick J Franzke, Stefanie Dehnen

Abstract read
In one paragraph

Article in Inorganic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jan ChristmannInstitute of Nanotechnology, Karlsruhe Institute of Technology (KIT), Kaiserstr. 12, 76131Karlsruhe, Germany.
Niklas RinnInstitute of Nanotechnology, Karlsruhe Institute of Technology (KIT), Kaiserstr. 12, 76131Karlsruhe, Germany.
Yannick J FranzkeInstitute of Nanotechnology, Karlsruhe Institute of Technology (KIT), Kaiserstr. 12, 76131Karlsruhe, Germany.ORCID 0000-0002-8344-113X
Stefanie DehnenInstitute of Nanotechnology, Karlsruhe Institute of Technology (KIT), Kaiserstr. 12, 76131Karlsruhe, Germany.ORCID 0000-0002-1325-9228

Funding

Deutsche Forschungsgemeinschaft 51870732Deutsche Forschungsgemeinschaft FOR 2824 398143140Karlsruhe Nano Micro Facility NA
6 · The paper itself

Abstract

The access of metal chalcogenide clusters with tunable properties remains challenging. For a given geometric cluster structure, chemical and physical properties are defined by the exact composition. With a binary metal chalcogenide cluster core, one can reach a certain degree of tunability, but an even finer definition is possible by expanding the concept to ternary cluster composition. As a case example, we address adamantane-type organotin chalcogenide clusters of the general composition [(RSn)4E6] (R = organic group, E = Se, Te) and herein report the targeted access of corresponding species exhibiting ternary clusters with two different types of chalcogen atoms involved, [(RSn)4E6-xE'x]. We report three different methods for the synthetic access of E/E' mixtures, including chalcogen exchange between preformed homochalcogenide clusters [(RSn)4E6] and[(RSn)4E'6] in solution. Extensive 119Sn NMR studies on corresponding reaction mixtures with different ratios of the starting materials, in combination with sophisticated quantum chemical calculations of the chemical shifts, unambiguously confirm that all statistically possible clusters form in solution. Isolation of selected species in single-crystalline form also indicates the existence of ternary cluster cores with a narrow dispersion of species around the given E:E' ratios. Our results represent an important step toward fine-tuning of metal chalcogenide cluster-based materials.

Identifiers

PMID42479614
PMCPMC13439662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.